Clinical Trial Update: Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxaloacetate for improving cognitive complaints in early-stage breast cancer survivors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Oxaloacetate (oxaloacetate)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Status: COMPLETED